NeurAxis, Inc. (NRXS:NYSEMKT) closed at $7.40 on October 23, 2026, down 2.63% on the day. The stock trades 20.7% below its 52-week high of $9.33 and 234.8% above its 52-week low of $2.21. Over the past year, it gained 112.0%. NeurAxis, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, NRXS closed higher on 121 days (48%). Its best day was December 22, 2025 (+25.16%) and its worst was February 23, 2026 (-14.10%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 1 time.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Find more stocks like NRXS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.